{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:44:53Z","timestamp":1777434293812,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jnma.2017.12.006","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T14:25:34Z","timestamp":1517495134000},"page":"480-485","source":"Crossref","is-referenced-by-count":25,"title":["Engaging United States Black Communities in HIV Pre-exposure Prophylaxis: Analysis of a PrEP Engagement Cascade"],"prefix":"10.1016","volume":"110","author":[{"given":"Helena Akua","family":"Kwakwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Bessias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donielle","family":"Sturgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahab","family":"Wahome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumar","family":"Gaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayla","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnma.2017.12.006_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.jnma.2017.12.006_bib2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1097\/QAD.0b013e3283629037","article-title":"Efficacy of pre-exposure prophylaxis for HIV-1 prevention among high risk heterosexuals: subgroup analyses from the Partners PrEP Study","volume":"27","author":"Murnane","year":"2013","journal-title":"AIDS"},{"issue":"27","key":"10.1016\/j.jnma.2017.12.006_bib3","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9883","key":"10.1016\/j.jnma.2017.12.006_bib4","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jnma.2017.12.006_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","article-title":"Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States","volume":"64","author":"Grohskopf","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jnma.2017.12.006_bib6","series-title":"FDA Approves First Drug for Reducing the Risk of Sexually Acquired HIV Infection","author":"United States Food and Drug Administration (FDA)","year":"2012"},{"issue":"9915","key":"10.1016\/j.jnma.2017.12.006_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(14)60137-9","article-title":"Uptake of PrEP for HIV slow among MSM","volume":"383","author":"Kirby","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jnma.2017.12.006_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001613","article-title":"Early experiences implementing pre exposure prophylaxis (PrEP) for HIV prevention in San Francisco","volume":"11","author":"Liu","year":"2014","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.jnma.2017.12.006_bib9","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/cid\/civ665","article-title":"If PrEP decreases HIV transmission, what is impeding its uptake?","volume":"61","author":"Mayer","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jnma.2017.12.006_bib10","unstructured":"Bush S, Ng L, Magnuson D, et\u00a0al. Significant uptake of truvada for Pre-exposure Prophylaxis (PrEP) Utilization in the US in Late 2014 \u2013 1Q2015. In: 10th International Conference on HIV Treatment and Prevention Adherence. June 28\u201330. Miami, FL. Abstract 74."},{"issue":"8","key":"10.1016\/j.jnma.2017.12.006_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/apc.2014.0303","article-title":"Minimal awareness and atalled uptake of pre-exposure prophylaxis (PrEP) among at risk, HIV-negative, black men who have sex with men","volume":"29","author":"Eaton","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"Suppl 3","key":"10.1016\/j.jnma.2017.12.006_bib12","article-title":"Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress","volume":"18","author":"Mayer","year":"2015","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jnma.2017.12.006_bib13","unstructured":"Mayer KH, Levine K, Grasso C, et\u00a0al. Recent increases in PrEP utilization at a Boston community health center among men who have sex with men, 2011\u20132014: transition from research to clinical practice. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI). February 22\u201325, 2016. Boston, MA. Abstract 972."},{"issue":"9","key":"10.1016\/j.jnma.2017.12.006_bib14","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jnma.2017.12.006_bib15","unstructured":"Mayer KH, Levine K, Maloney KM, et\u00a0al. Increasing HIV suppression, PrEP use, and STDs in Boston MSM accessing primary care. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI); February 22\u201325, 2016. Boston, MA. Abstract 890."},{"key":"10.1016\/j.jnma.2017.12.006_bib16","volume":"vol. 27","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.jnma.2017.12.006_bib17","unstructured":"Bush S, Magnuson D, Rawlings MK et\u00a0al. Racial characteristics of FTC\/TFD for pre-exposure prophylaxis users in the US. In: ASM Microbe 2016\/ICAAC 2016. Boston, MA. June 16\u201320, 2016. Abstract 2651."},{"key":"10.1016\/j.jnma.2017.12.006_bib18","unstructured":"Hess K, Hu X, Lansky A et\u00a0al. Estimating the lifetime risk of a diagnosis of HIV infection in the United States. In: 23rd Conference on Retroviruses and Opportunistic Infection (CROI); February 22\u201325, 2016. Boston, MA. Abstract 52."},{"issue":"46","key":"10.1016\/j.jnma.2017.12.006_bib19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","article-title":"Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition-United States, 2015","volume":"64","author":"Smith","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jnma.2017.12.006_bib20","series-title":"Epitools: Epidemiology Tools. R Package Version 0.5-7","author":"Aragon","year":"2012"},{"issue":"7","key":"10.1016\/j.jnma.2017.12.006_bib21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10461-016-1407-9","article-title":"Attitudes toward HIV pre-exposure prophylaxis in a United States urban clinic population","volume":"20","author":"Kwakwa","year":"2016","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jnma.2017.12.006_bib22","unstructured":"Rolle CM, Siegler AS, Sanchez T, et\u00a0al. Challenges of translating PrEP interest into uptake among young black MSM in Atlanta. In: 24th Conference on Retroviruses and Opportunistic Infections (CROI). Feb 13\u201316, 2017. Seattle, WA. Abstract 90."},{"key":"10.1016\/j.jnma.2017.12.006_bib23","unstructured":"Delaney KP, Sanchez T, Bowles K, et\u00a0al. Awareness and use of PrEP appear to be increasing among internet samples of United States MSM. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI). February 22\u201325, 2016. Boston, MA. Abstract 889."},{"issue":"1","key":"10.1016\/j.jnma.2017.12.006_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QAI.0000000000001165","article-title":"The right people, right places, and right practices: disparities in PrEP access among African American men, women and MSM in the deep South","volume":"74","author":"Elopre","year":"2017","journal-title":"J\u00a0Acquir Immun Def Syndr"},{"key":"10.1016\/j.jnma.2017.12.006_bib25","unstructured":"Gibson S, Crouch PC, Hecht J, et\u00a0al. Eliminating barriers to increase uptake of PrEP in a community-based clinic in San Francisco. In: 21st International AIDS Conference (AIDS2016). July 18\u201322, 2016. Durban, South Africa. Abstract FRAE0104."},{"issue":"11","key":"10.1016\/j.jnma.2017.12.006_bib26","first-page":"1","article-title":"Women want pre-exposure prophylaxis but are advised against it by their HIV-positive counterparts","volume":"6","author":"Goparaju","year":"2015","journal-title":"J\u00a0AIDS Clin Res"},{"key":"10.1016\/j.jnma.2017.12.006_bib27","unstructured":"Patel RR, Mena L, Nunn A, et\u00a0al. PLos One. https:\/\/doi.org\/10.1371\/journal.pone.0178.737."},{"key":"10.1016\/j.jnma.2017.12.006_bib28","unstructured":"Katz D, Dombrowski JC, Bell T, et\u00a0al. STD partner services to monitor and promote PrEP use among men who have sex with men. In: 24th Conference on Retroviruses and Opportunistic Infections (CROI). February 13\u201316, 2017. Seattle, WA. Abstract 89."},{"key":"10.1016\/j.jnma.2017.12.006_bib29","unstructured":"Wheeler D, Fields S, Nelson L, et\u00a0al. HPYN 073: PrEP uptake and use by Black men who have sex with men in 3 US cities. In: 23rd Conferences on Retroviruses and Opportunistic Infections (CROI). February 22\u201325, 2016. Boston, MA. Abstract 883LB."}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002796841730189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002796841730189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:12:40Z","timestamp":1538179960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002796841730189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S002796841730189X"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2017.12.006","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}